John A. Rohde

461 total citations
9 papers, 314 citations indexed

About

John A. Rohde is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Genetics. According to data from OpenAlex, John A. Rohde has authored 9 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 4 papers in Molecular Biology and 1 paper in Genetics. Recurrent topics in John A. Rohde's work include Cardiomyopathy and Myosin Studies (7 papers), Cardiovascular Effects of Exercise (6 papers) and Muscle Physiology and Disorders (3 papers). John A. Rohde is often cited by papers focused on Cardiomyopathy and Myosin Studies (7 papers), Cardiovascular Effects of Exercise (6 papers) and Muscle Physiology and Disorders (3 papers). John A. Rohde collaborates with scholars based in United States. John A. Rohde's co-authors include David D. Thomas, Joseph M. Muretta, Osha Roopnarine, Christopher M. Yengo, Ewa Próchniewicz, Darshan V. Trivedi, Edward P. Debold, William C. Unrath, Dean L. Sicking and Ronald K. Faller and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biophysical Journal.

In The Last Decade

John A. Rohde

9 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John A. Rohde United States 7 275 176 38 38 20 9 314
Petr G. Vikhorev United Kingdom 11 271 1.0× 187 1.1× 33 0.9× 55 1.4× 26 1.3× 15 358
Osha Roopnarine United States 14 382 1.4× 282 1.6× 59 1.6× 64 1.7× 36 1.8× 21 476
Cristina M. Risi United States 10 267 1.0× 200 1.1× 41 1.1× 55 1.4× 5 0.3× 18 358
Irene Pertici Italy 12 174 0.6× 158 0.9× 41 1.1× 53 1.4× 12 0.6× 24 287
Bogdan Iorga Germany 12 307 1.1× 238 1.4× 30 0.8× 38 1.0× 15 0.8× 19 409
Ryan D. Mateja United States 5 301 1.1× 209 1.2× 40 1.1× 53 1.4× 20 1.0× 5 406
Ziqian Yan United Kingdom 8 254 0.9× 183 1.0× 26 0.7× 26 0.7× 11 0.6× 9 339
Luca Melli Italy 9 201 0.7× 177 1.0× 85 2.2× 79 2.1× 15 0.8× 10 311
Galina V. Kopylova Russia 13 375 1.4× 246 1.4× 37 1.0× 59 1.6× 6 0.3× 58 448
Kimberly A. Palmiter United States 11 670 2.4× 438 2.5× 57 1.5× 69 1.8× 17 0.8× 13 722

Countries citing papers authored by John A. Rohde

Since Specialization
Citations

This map shows the geographic impact of John A. Rohde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Rohde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Rohde more than expected).

Fields of papers citing papers by John A. Rohde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Rohde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Rohde. The network helps show where John A. Rohde may publish in the future.

Co-authorship network of co-authors of John A. Rohde

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Rohde. A scholar is included among the top collaborators of John A. Rohde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Rohde. John A. Rohde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Hansen, Scott L., Chih Hung Lo, Anil K. Pandey, et al.. (2022). Fluorescence Lifetime Measurement of Prefibrillar Sickle Hemoglobin Oligomers as a Platform for Drug Discovery in Sickle Cell Disease. Biomacromolecules. 23(9). 3822–3830. 5 indexed citations
2.
Rohde, John A., et al.. (2020). FRET and optical trapping reveal mechanisms of actin activation of the power stroke and phosphate release in myosin V. Journal of Biological Chemistry. 295(51). 17383–17397. 17 indexed citations
3.
Rohde, John A., Osha Roopnarine, David D. Thomas, & Joseph M. Muretta. (2018). Mavacamten stabilizes an autoinhibited state of two-headed cardiac myosin. Proceedings of the National Academy of Sciences. 115(32). E7486–E7494. 105 indexed citations
4.
Rohde, John A., William C. Unrath, Darshan V. Trivedi, et al.. (2018). Converter domain mutations in myosin alter structural kinetics and motor function. Journal of Biological Chemistry. 294(5). 1554–1567. 14 indexed citations
5.
Próchniewicz, Ewa, et al.. (2017). A Cardiomyopathy Mutation in the Myosin Essential Light Chain Alters Actomyosin Structure. Biophysical Journal. 113(1). 91–100. 16 indexed citations
6.
Rohde, John A., David D. Thomas, & Joseph M. Muretta. (2017). Heart failure drug changes the mechanoenzymology of the cardiac myosin powerstroke. Proceedings of the National Academy of Sciences. 114(10). E1796–E1804. 71 indexed citations
7.
Rohde, John A., David D. Thomas, & Joseph M. Muretta. (2016). Structural and Biochemical Kinetics of Cardiac Myosin and its Perturbation by a Known Heart Failure Drug Investigated with Transient Time-Resolved FRET. Biophysical Journal. 110(3). 296a–296a. 1 indexed citations
8.
Muretta, Joseph M., et al.. (2015). Direct real-time detection of the structural and biochemical events in the myosin power stroke. Proceedings of the National Academy of Sciences. 112(46). 14272–14277. 79 indexed citations
9.
Sicking, Dean L., et al.. (2000). CRASH TESTING OF MICHIGAN'S TYPE B (W-BEAM) GUARDRAIL SYSTEM - PHASE II. Insecta mundi. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026